Haemonetics | HAE - Equity Capital And Reserves


Haemonetics reported $911.45M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Cerus USD 61.46M 6.04M Sep/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 249.82M 12.7B Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
ICU Medical USD 2.12B 3.42M Dec/2025
Intuitive Surgical USD 17.47B 349.5M Mar/2026
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Neogen USD 2.1B 2.09M Dec/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Plus Therapeutics USD 4M 1.06M Dec/2025
Quidel USD 1.92B 115.9M Dec/2025
ResMed USD 6.32B 199.61M Dec/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Surmodics USD 111.31M 7.59M Jun/2025
Teleflex USD 3.12B 697.09M Dec/2025
Terumo JPY 1.52T 84.79B Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
US Physical Therapy USD 476.43M 27.14M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025